Feasibility, endocrine and anti-tumour effects of a triple endocrine therapy with tamoxifen, a somatostatin analogue and an antiprolactin in post-menopausal metastatic breast cancer: a randomized study with long-term follow-up
(Q36295053)
scientific article published on January 1, 1998
scientific article published on January 1, 1998
Language: